期刊文献+

围手术期强化他汀治疗对肾动脉狭窄介入治疗后炎性因子及肾功能的影响

Effect of Perioperative Intensive Statin Therapy on Inflammatory Factors and Renal Function after Interventional Treatment of Renal Artery Stenosis
下载PDF
导出
摘要 目的探究围手术期中强化他汀治疗对肾动脉狭窄介入治疗后的炎性因子以及肾功能方面的影响。方法方便选取菏泽鲁心医院、济南市中心人民医院等院于2013年12月—2016年3月接受肾动脉狭窄手术治疗的患者280例,采用随机分组的方式将患者平均分成实验组和观察组,在手术前后分别观察患者的炎性因子水平以及反映肾功能的指标,并对两组患者进行对比分析。结果在围手术期中采用强化他汀治疗的实验组患者的CRP、IL-6的值、炎性因子水平分别(5.17±2.07)、(25.58±3.96)和(163.67±5.31),而采用常规治疗的对照组中的CRP、IL-6、血肌酐值在手术后的值分别为(6.35±1.95)、(32.12±4.73)和(169.75±5.19),手术后CRP、IL-6的值,血肌酐值水平差异有统计学意义,P<0.05。结论在围手术期中强化他汀治疗有助于对肾动脉狭窄介入治疗后炎性因子及肾功能的改善,具有显著疗效。 Objective To explore the perioperative intensive statin therapy on inflammatory factors after interventional treat-ment of renal artery stenosis and renal function.Methods A total in Heze heart hospital, Jinan City People&#39;s Hospital, school accept 280 cases of patients from December 2013 to March 2016 with renal artery stenosis Surgical treatment, using ran-domized patients were divided into the experimental group and the observation group, before and after the operation were observed in patients with inflammatory factor level and index of renal function, and carries on the comparative analysis of two groups of patients. Results In the peri operation period of the reinforcement value of CRP and interleukin-6 in statin treated patients in the experimental group, inflammatory factor levels were (5.17±2.07), (25.58±3.96) (163.67±5.31), and the conventional treatment control group of CRP, IL-6, serum creatinine value in the postoperative values were (6.35 ±1.95), (32.12±4.73)、 (169.75±5.19), value of CRP and IL-6 after surgery, blood creatinine value level with significant difference (P﹤0.05). Conclusion Intensive statin therapy in perioperative period is helpful to the improvement of inflammatory factors and renal function after interventional treatment of renal artery stenosis.
出处 《中外医疗》 2016年第18期146-147,152,共3页 China & Foreign Medical Treatment
基金 首都临床特色应用研究培育项目(Z131100006813031)
关键词 围手术期 强化他汀治疗 肾动脉狭窄 Perioperative period Intensive statin therapy Renal artery stenosis
  • 相关文献

参考文献7

二级参考文献15

  • 1李惠清,于海英.阿托伐他汀联合阿魏酸钠治疗糖尿病肾病肾间质纤维化的临床研究[J].中国生化药物杂志,2014,34(4):120-122. 被引量:16
  • 2TACHIBANA H, OGAWA D, SOGAWA N, et al. Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-in- dueed diabeticmice[J]. Am J Physiol Renal Physiol, 2014, 306(1): FI05-F115.
  • 3MISE K, HOSHINO J, UBARA Y, et al. Renal prognosis a longtime after renal biopsy on patients with diabetic nephropathy[J]. Nephrol Dial Transplant, 2014, 29(1): 109-118.
  • 4SHIMIZU M, FURUICHI K, TOYAMA T, et al. Long-term out- comes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy[J]. Diabetes Care, 2013, 36(11): 3655-3662.
  • 5SAGAR SK, ZHANG C, GUO Q, et al. Role of expression of endothelin-I and angiatensin-II and hypoxia-inducible factor-I ct in the kidney tissues of patients with diabetic nephropathy [J]. Saudi J Kidney Dis Transpl, 2013, 24(5): 959-964.
  • 6PRASAD N, GUPTA P, JAIN M, et al. Outcomes of de novo allograft diabetic nephropathy in renal allograft recipients [J]. Exp Clin Transplant, 2013, 11(3): 215-221.
  • 7RUTYER MK, PRAIS HR, CHARLTON-MENYS V, et al. Pro- tection Against Nephropathy in Diabetes with Atorvastatin (PAN- DA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin[J]. Diabet Med, 2011, 28(1): 100-108.
  • 8M.Sendeski,A.Patzak,T.L.Pallone,C. Cao,A .Persson,P.B.Persson,李艳(译),刘竞艳(校).碘克沙醇引起髓质直血管降支收缩和对比剂肾病的风险[J].国际医学放射学杂志,2009,32(4):390-390. 被引量:20
  • 9胡越成,张琦,丛洪良.曲美他嗪对心肾功能的保护作用[J].中华老年心脑血管病杂志,2013,15(1):98-101. 被引量:30
  • 10郑博,王新刚,龚艳君,李建平,陈明,霍勇,洪涛.直接经皮冠状动脉介入治疗术前负荷剂量阿托伐他汀治疗对急性心肌梗死患者近期预后的影响[J].中国介入心脏病学杂志,2013,21(1):41-45. 被引量:40

共引文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部